NCT00946621View on ClinicalTrials.gov

To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
Hypertension
Interventions
DRUG

Ramipril 10 mg Capsule (Sandoz)

DRUG

Altace (Ramipril) 10 mg Capsule (Aventis Pharmaceutical)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY